Early HPV testing could detect sexually-transmitted oral cancer

Antibodies to a high-risk type of human papillomavirus (HPV16) could help detect oropharyngeal cancer several years before the clinical onset of the disease, reveals a new study from the International Agency for Research on Cancer (IARC) in cooperation with the German Cancer Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the Journal of Clinical Oncology.

A R Kreimer, M Johansson, T Waterboer, R Kaaks, J Chang-Claude, D Drogen, A Tjønneland et al.
Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer
Journal of Clinical Oncology published online on June 17, 2013; DOI: 10.1200/JCO.2012.47.2738
Read IARC Press Release 219Read article